ArticleArthritis & rheumatology (Hoboken, N.J.)2020

Interleukin-17 Inhibition in Spondyloarthritis Is Associated With Subclinical Gut Microbiome Perturbations and a Distinctive Interleukin-25-Driven Intestinal Inflammation.

Julia Manasson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.